Navaja, Baby Girl .
HRN: 28-31-68 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/30/2025
AMPICILLIN 500MG (VIAL)
12/30/2025
01/06/2026
IV
145mg
Q12
PSNB (PROM X 15hrs)
Checking Initial Appropriateness
12/30/2025
GENTAMICIN 40MG/ML, 2ML (AMP)
12/30/2025
01/06/2026
IV
15mg
Q24
PSNB (PROM X 15hrs)
Checking Initial Appropriateness